The Hague • 14 May 2025
Managing erectile dysfunction (ED) symptoms and supporting men’s self-care are the focus of a new handbook published today by the International Pharmaceutical Federation (FIP). This resource aims to equip pharmacists with the knowledge, tools, and confidence to provide effective, people-centred care within accessible pharmacy settings.
ED is the most common male sexual dysfunction, affecting up to half of men over the age of 50, with rising prevalence due to ageing populations and comorbidities such as diabetes and cardiovascular disease. However, stigma and limited access to appropriate care often lead to underdiagnosis and undertreatment. Recognising the pharmacist’s trusted position in communities, the new publication offers practical, evidence-based guidance to address these barriers.
The handbook was developed under FIP’s Practice Transformation Programme on Non-communicable Diseases (NCDs), which supports pharmacists in improving prevention, screening, and management of NCDs. It covers key topics including risk assessment, safe use of phosphodiesterase type 5 inhibitors (PDE5Is), lifestyle changes, counselling, referral pathways, and pharmacists’ professional and ethical responsibilities in ED management.
The growing risks of self-medication, substandard or falsified medicines treatments, and online misinformation further reinforce the importance of pharmacists in safeguarding patients through safe and informed care.
“Pharmacists are often the first healthcare professionals men turn to when they experience symptoms of erectile dysfunction. This handbook empowers pharmacists to go beyond dispensing medicines — to start sensitive conversations, recognise red flags, provide evidence-based guidance, and refer patients when needed, while also identifying underlying health conditions contributing to ED and supporting early detection of serious comorbidities, such as cardiovascular disease and diabetes,” said FIP president Mr Paul Sinclair.
The handbook was developed with contributions from Australia, Canada, GB, India, Ireland, New Zealand and Spain.
“In many parts of the world, access to well-informed physicians with sexual health knowledge is lacking. The ability to provide that care at the local pharmacy is cost-effective. The critical information contained within this handbook should result in improved patient and partner outcomes,” said Dr Gerald Brock, professor emeritus of surgery, Division of Urology, Western University, Canada, past-president, International Society for Sexual Medicine and medical director, Advanced Medical and Surgical Group.
Notes for editors
About FIP The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists, pharmaceutical scientists and pharmacy educators, and is in official relations with the World Health Organization. Through its 158 member organisations, it represents over four million practitioners and scientists around the world. www.fip.org
PRESS CONTACT
Ms Laila Ghorab
Communications Manager
International Pharmaceutical Federation (FIP)
Email laila@fip.org